PUBLISHER: Acute Market Reports | PRODUCT CODE: 1180749
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1180749
Pigmentation Disorders Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
Industry Outlook
The pigmentation disorders treatment market is set to reach US$ 12,313.2 Mn by 2030 from US$ 6,777.4 Mn in 2021 showcasing a steady growth at a compound annual growth rate (CAGR) of 6.9% during the forecast period from 2022 to 2030. The American Association for Pediatric Ophthalmology and Strabismus (AAPOS) claims that 1 in 17,000 people suffer with some form of Albinism. Vitiligo is a lifelong condition and there is no permanent cure; however, exposure to UVA and UVB phototherapy stimulates the growth of melanocytes on the skin patches and treats hypopigmentation to a certain extent. In the present scenario, pharmaceutical manufacturers are using topical creams in combination such as adapalene/benzoylperoxide, adapalene/clindamycin for the treatment of face dark spots created due to acne vulgaris. Currently, imiquimod cream (MEDA Pharma GmbH & Co. KG) is in phase 3 clinical trials being tested for better clinical outcomes in the treatment of Solar Lentigines.
North America currently dominates the pigmentation disorders market on account of growing melasma incidence in pregnant women. Existence of well-developed healthcare infrastructure and presence of major players prove beneficial in treating patients suffering with post inflammatory hyperpigmentation in North America. The pigmentation disorders treatment market is growing at a rapid pace in Asia Pacific on account of key drivers such as competition exerted by local manufacturers. The other factors promoting growth are supportive regulatory norms favoring growth of topical drugs, and rise in per capita income.
Rising incidence of skin hyperpigmentation to cater excellent growth for topical drugs
In the current scenario, topical drugs are dominating the treatment type segment owing to better clinical outcomes in patients suffering with pigmentation disorders. The topical drugs commonly prescribed throughout the globe are azelaic acid, hydroquinone, L-ascorbic acid etc. Chemical peels have found prominence in the last 2 decades to treat facial hyperpigmentation disorders. They are effective in treating face wrinkles caused due to aging and harmful sun light, improve the appearance of mild scars and treat dark spots caused due to acne. Dermabrasion has developed a niche market owing to its popularity in solving facial defects such as pox scars, accident scars, age spots and dull skin. Rise in per capita income and upgraded lifestyle are the driving factors for the growth of phototherapy and laser therapy for treating pigmentation disorders. However the high costs associated with photo and laser therapy is a limitation for its market growth.
Higher incidence of melasma in women post pregnancy will result in impressive double-digit growth
Melasma often known as chloasma occurs in 90% of the pregnant women. It results in discoloration of the skin in patches usually in the forearms, chin, cheeks, bridge of the nose and forehead. The incidence of melasma is higher in dark skinned people, in comparison to fair skinned people. The chief factors responsible for the occurrence of melasma in women are hormones, pregnancy and use of birth control pills. Melasma results in huge demand for topical drugs, chemical peels and microdermabrasion for dermal treatment. Post inflammatory hyperpigmentation is set to register growth at a rapid pace due to key factors such as increasing number of domestic accidents resulting in dermal burns and skin tissue abrasion, resulting in hyperpigmentation due to excess melanin production during healing process.
Increasing competition from local players in Asia Pacific will result in tremendous growth during the forecast period
North America accounts for 42% of the market share and thus dominates the global pigmentation disorders treatment market. The important parameters responsible for the burgeoning growth of North America is the presence of market leaders pioneering in dermatology products such as Galderma S.A., RXi Pharmaceuticals Corporation and Vivier Pharma. Rising number of patients suffering with skin pigmentation disorders due to harmful exposure to UV radiation and increasing public awareness related to skin diseases propels the pigmentation disorders treatment market growth in Europe. Asia Pacific is set to register faster growth owing to the competition created by local players. Increase in per capita income and enhanced funding by the pharmaceutical companies in the research and development to enhance the quality and efficacy of dermal products impose a positive effect on the market growth in Asia Pacific.
In order to understand the prevailing market trend and quantitative analysis the market assessment of pigmentation disorders treatment market is performed. Product portfolio is helpful in giving valuable information of the medicines being currently used for the treatment of pigmentation disorders. The major players spearheading the pigmentation disorders treatment market are ALLERGAN, Bayer AG, Galderma S.A., EpiPharm AG, Pierre Fabre Laboratories, La-Roche Posay, Obagi Cosmeceuticals LLC, RXi Pharmaceuticals Corporation, SkinCeuticals and Vivier Pharma.
Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Pigmentation Disorders Treatment market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report:
Micro and macro environment factors that are currently influencing the Pigmentation Disorders Treatment market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Market Segmentation
Treatment
Topical Drugs
Chemical Peels
Microdermabrasion
Phototherapy
Laser Therapy
Disease
Melasma
Albinism
Vitiligo
Post-Inflammatory Hyperpigmentation
Others (Solar Lentigines, Acne Vulgaris, etc.)
Region Segment (2020-2030; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Global Impact of COVID-19 Segment (2020-2021; US$ Million )
Pre COVID-19 situation
Post COVID-19 situation
Key questions answered in this report:
What are the key micro and macro environmental factors that are impacting the growth of Pigmentation Disorders Treatment market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2030.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Pigmentation Disorders Treatment market?
Which is the largest regional market for Pigmentation Disorders Treatment market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Pigmentation Disorders Treatment market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Pigmentation Disorders Treatment market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Pigmentation Disorders Treatment Market
- 2.2. Global Pigmentation Disorders Treatment Market, By Treatment, 2021 (US$ Million)
- 2.3. Global Pigmentation Disorders Treatment Market, By Disease, 2021 (US$ Million)
- 2.4. Global Pigmentation Disorders Treatment Market, By Geography, 2021 (US$ Million)
- 2.5. Attractive Investment Proposition by Geography, 2021
3. Pigmentation Disorders Treatment Market: Competitive Analysis
- 3.1. Market Positioning of Key Pigmentation Disorders Treatment Market Vendors
- 3.2. Strategies Adopted by Pigmentation Disorders Treatment Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2021 Versus 2030
4. Pigmentation Disorders Treatment Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Pigmentation Disorders Treatment Market Value, 2020 - 2030, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
5. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2021 Versus 2030
- 5.3. Market Segmentation
- 5.3.1. Topical Drugs
- 5.3.2. Chemical Peels
- 5.3.3. Microdermabrasion
- 5.3.4. Phototherapy
- 5.3.5. Laser Therapy
6. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2021 Versus 2030
- 6.3. Market Segmentation
- 6.3.1. Melasma
- 6.3.2. Albinism
- 6.3.3. Vitiligo
- 6.3.4. Post-Inflammatory Hyperpigmentation
- 6.3.5. Others (Solar Lentigines, Acne Vulgaris, etc.)
7. North America Pigmentation Disorders Treatment Market, 2020-2030, USD (Million)
- 7.1. Market Overview
- 7.2. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 7.3. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 7.4.Pigmentation Disorders Treatment Market: By Region, 2020-2030, USD (Million)
- 7.4.1.North America
- 7.4.1.1. U.S.
- 7.4.1.1.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 7.4.1.1.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 7.4.1.2. Canada
- 7.4.1.2.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 7.4.1.2.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 7.4.1.3. Rest of North America
- 7.4.1.3.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 7.4.1.3.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 7.4.1.1. U.S.
- 7.4.1.North America
8. UK and European Union Pigmentation Disorders Treatment Market, 2020-2030, USD (Million)
- 8.1. Market Overview
- 8.2. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 8.3. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 8.4.Pigmentation Disorders Treatment Market: By Region, 2020-2030, USD (Million)
- 8.4.1.UK and European Union
- 8.4.1.1. UK
- 8.4.1.1.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 8.4.1.1.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 8.4.1.2. Germany
- 8.4.1.2.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 8.4.1.2.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 8.4.1.3. Spain
- 8.4.1.3.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 8.4.1.3.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 8.4.1.4. Italy
- 8.4.1.4.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 8.4.1.4.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 8.4.1.5. France
- 8.4.1.5.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 8.4.1.5.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 8.4.1.6. Rest of Europe
- 8.4.1.6.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 8.4.1.6.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 8.4.1.1. UK
- 8.4.1.UK and European Union
9. Asia Pacific Pigmentation Disorders Treatment Market, 2020-2030, USD (Million)
- 9.1. Market Overview
- 9.2. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 9.3. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 9.4.Pigmentation Disorders Treatment Market: By Region, 2020-2030, USD (Million)
- 9.4.1.Asia Pacific
- 9.4.1.1. China
- 9.4.1.1.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 9.4.1.1.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 9.4.1.2. Japan
- 9.4.1.2.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 9.4.1.2.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 9.4.1.3. India
- 9.4.1.3.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 9.4.1.3.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 9.4.1.4. Australia
- 9.4.1.4.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 9.4.1.4.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 9.4.1.5. South Korea
- 9.4.1.5.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 9.4.1.5.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 9.4.1.6. Rest of Asia Pacific
- 9.4.1.6.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 9.4.1.6.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 9.4.1.1. China
- 9.4.1.Asia Pacific
10. Latin America Pigmentation Disorders Treatment Market, 2020-2030, USD (Million)
- 10.1. Market Overview
- 10.2. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 10.3. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 10.4.Pigmentation Disorders Treatment Market: By Region, 2020-2030, USD (Million)
- 10.4.1.Latin America
- 10.4.1.1. Brazil
- 10.4.1.1.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 10.4.1.1.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 10.4.1.2. Mexico
- 10.4.1.2.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 10.4.1.2.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 10.4.1.3. Rest of Latin America
- 10.4.1.3.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 10.4.1.3.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 10.4.1.1. Brazil
- 10.4.1.Latin America
11. Middle East and Africa Pigmentation Disorders Treatment Market, 2020-2030, USD (Million)
- 11.1. Market Overview
- 11.2. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 11.3. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 11.4.Pigmentation Disorders Treatment Market: By Region, 2020-2030, USD (Million)
- 11.4.1.Middle East and Africa
- 11.4.1.1. GCC
- 11.4.1.1.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 11.4.1.1.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 11.4.1.2. Africa
- 11.4.1.2.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 11.4.1.2.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 11.4.1.3. Rest of Middle East and Africa
- 11.4.1.3.1. Pigmentation Disorders Treatment Market: By Treatment, 2020-2030, USD (Million)
- 11.4.1.3.1. Pigmentation Disorders Treatment Market: By Disease, 2020-2030, USD (Million)
- 11.4.1.1. GCC
- 11.4.1.Middle East and Africa
12. Company Profile
- 12.1. ALLERGAN PLC
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Portfolio
- 12.1.4. Strategic Initiatives
- 12.2. Bayer AG
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Portfolio
- 12.2.4. Strategic Initiatives
- 12.3. Galderma S.A.
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Portfolio
- 12.3.4. Strategic Initiatives
- 12.4. EpiPharm AG
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Portfolio
- 12.4.4. Strategic Initiatives
- 12.5. Pierre Fabre Laboratories
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Portfolio
- 12.5.4. Strategic Initiatives
- 12.6. La Roche-Posay Laboratoire Pharmaceutique
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Portfolio
- 12.6.4. Strategic Initiatives
- 12.7. Obagi Cosmeceuticals LLC
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Portfolio
- 12.7.4. Strategic Initiatives
- 12.8. RXi Pharmaceuticals Corporation
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Portfolio
- 12.8.4. Strategic Initiatives
- 12.9. SkinCeuticals, Inc.
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Portfolio
- 12.9.4. Strategic Initiatives
- 12.10. Vivier Pharma, Inc.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Portfolio
- 12.10.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 2 Global Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 3 North America Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 4 North America Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 5 U.S. Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 6 U.S. Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 7 Canada Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 8 Canada Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 9 Rest of North America Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 10 Rest of North America Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 11 UK and European Union Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 12 UK and European Union Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 13 UK Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 14 UK Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 15 Germany Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 16 Germany Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 17 Spain Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 18 Spain Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 19 Italy Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 20 Italy Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 21 France Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 22 France Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 23 Rest of Europe Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 24 Rest of Europe Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 25 Asia Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 26 Asia Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 27 China Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 28 China Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 29 Japan Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 30 Japan Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 31 India Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 32 India Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 33 Australia Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 34 Australia Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 35 South Korea Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 36 South Korea Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 37 Latin America Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 38 Latin America Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 39 Brazil Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 40 Brazil Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 41 Mexico Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 42 Mexico Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 43 Rest of Latin America Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 44 Rest of Latin America Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 45 Middle East and Africa Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 46 Middle East and Africa Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 47 GCC Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 48 GCC Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 49 Africa Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 50 Africa Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
- TABLE 51 Rest of Middle East and Africa Pigmentation Disorders Treatment Market By Treatment, 2020-2030, USD (Million)
- TABLE 52 Rest of Middle East and Africa Pigmentation Disorders Treatment Market By Disease, 2020-2030, USD (Million)
List of Figures
- FIG. 1 Global Pigmentation Disorders Treatment Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Pigmentation Disorders Treatment Market: Quality Assurance
- FIG. 5 Global Pigmentation Disorders Treatment Market, By Treatment, 2021
- FIG. 6 Global Pigmentation Disorders Treatment Market, By Disease, 2021
- FIG. 7 Global Pigmentation Disorders Treatment Market, By Geography, 2021
- FIG. 8 Market Geographical Opportunity Matrix - Global Pigmentation Disorders Treatment Market, 2021
- FIG. 9 Market Positioning of Key Pigmentation Disorders Treatment Market Players, 2021
- FIG. 10 Global Pigmentation Disorders Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
- FIG. 11 Global Pigmentation Disorders Treatment Market, By Treatment, 2021 Vs 2030, %
- FIG. 12 Global Pigmentation Disorders Treatment Market, By Disease, 2021 Vs 2030, %
- FIG. 13 U.S. Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 14 Canada Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 15 Rest of North America Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 16 UK Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 17 Germany Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 18 Spain Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 19 Italy Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 20 France Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 21 Rest of Europe Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 22 China Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 23 Japan Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 24 India Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 25 Australia Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 26 South Korea Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 27 Rest of Asia Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 28 Brazil Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 29 Mexico Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 30 Rest of Latin America Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 31 GCC Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 32 Africa Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
- FIG. 33 Rest of Middle East and Africa Pigmentation Disorders Treatment Market (US$ Million), 2020 - 2030
